Post-Traumatic Stress Disorders Clinical Trial
Official title:
Placebo-Controlled Trial of Risperidone Augmentation for SSRI-Resistant Civilian PTSD
The purpose of this study is to determine whether the administration of risperidone is effective in the treatment of selective serotonin reuptake inhibitor (SSRI)-resistant post-traumatic stress disorder (PTSD) in civilians.
Individuals with PTSD often experience anxiety attacks, nightmares, or repeated unwanted
memories after experiencing or witnessing life-threatening events, such as serious accidents
or natural disasters, or traumatic events such as physical or sexual abuse.
Risperidone has been approved by the Food and Drug Administration for the treatment of
psychotic disorders and has been found helpful for PTSD and depression, but is still
considered investigational for the purposes of this study.
All qualified participants will be started on sertraline (Zoloft) for eight weeks. Patients
who are still symptomatic at the end of this phase, will be invited to join the second
portion of the study where they will be randomly assigned to receive risperidone or placebo
(sugar pill) in addition to the sertraline. Participants will be monitored regularly for
medication effects, adverse events, and PTSD symptoms.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04032301 -
Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
|
Phase 1 | |
Withdrawn |
NCT00641173 -
Early Intervention for Post Traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT00564317 -
KIDNET vs Meditation/Relaxation - a Dissemination Randomized Controlled Trial for the Treatment of Traumatized Children After War in Sri Lanka
|
Phase 3 | |
Recruiting |
NCT02512445 -
Trauma Informed Guilt Reduction Therapy
|
N/A | |
Completed |
NCT00100490 -
Immune and Endocrine Function in Post-Traumatic Stress Disorder
|
N/A | |
Terminated |
NCT03605342 -
Optimal Treatment of Veterans With PTSD and Comorbid OUD
|
Phase 2 | |
Terminated |
NCT02824445 -
To Evaluate the Efficacy of EEG-guided Magnetic Resonant Therapy in War Veterans With Posttraumatic Stress Disorder
|
N/A | |
Recruiting |
NCT03152175 -
Posttraumatic Stress Disorders in Police, Correctional Service Officers, and 911 Operators
|
Phase 2 | |
Completed |
NCT02080351 -
A Simple Cognitive Task to Reduce the Build-Up of Flashbacks After a Road Traffic Accident
|
N/A | |
Completed |
NCT00974402 -
Psychotherapy Treatment of Deployment-Related PTSD in Primary Care Settings
|
N/A | |
Recruiting |
NCT00134446 -
Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder
|
Phase 4 | |
Not yet recruiting |
NCT02384369 -
Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder
|
Phase 2 | |
Completed |
NCT00120250 -
Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress Disorder
|
Phase 4 | |
Completed |
NCT00039715 -
Effects of Hydrocortisone in Patients With Post-Traumatic Stress Disorder
|
N/A | |
Recruiting |
NCT04368689 -
The Feasibility and Examination of the Effects of Floatation-based REST on a Community Sample With PTSD
|
N/A | |
Completed |
NCT01060553 -
Pilot of Acupuncture to Improve Quality of Life in Veterans With TBI and PTSD
|
N/A | |
Completed |
NCT00227357 -
The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration
|
N/A | |
Completed |
NCT02927288 -
Identifying Biomarkers That Distinguish PTSD and mTBI Using Advanced Magnetic Resonance Spectroscopy
|
N/A | |
Completed |
NCT01278316 -
Rural Veterans With Post-traumatic Stress Disorder (PTSD) And Comorbid Mild Traumatic Brain Injury (TBI): A Feasibility Study
|
N/A | |
Completed |
NCT00778960 -
Mechanistic Pathways of Mindfulness Meditation in Post-traumatic Stress Disorder.
|
N/A |